Delivery Order SPE2DR25D1205-SPE2DR26F0VM3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $28,274.55 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5 mL) with an ultimate completion date of August 28, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract represents a continuation of AmerisourceBergen's role as a critical federal medical procurement vendor, particularly...
- The Defense Logistics Agency awarded a $86,365.07 delivery order to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) under a firm fixed-price contract type. The award, announced on July 16, 2025, with an ultimate completion date of July 17, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this medical supply delivery order, which will be performed at the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,703.93 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5ML) with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in...
- The Defense Logistics Agency awarded a $10,990.43 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Prevnar 20 vaccine in 0.5 milliliter syringes. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $22,383.40 for PREVNAR 20 syringes (0.5mL) under a firm fixed-price contract. The award, issued on June 23, 2025, with an ultimate completion date of June 24, 2025, represents a competitively awarded non-set-aside procurement. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $12,071.78 firm fixed price delivery order to AmerisourceBergen Drug Corp for Prevnar 20 syringes (0.5ml) with an ultimate completion date of July 30, 2025. This non-set-aside competitive award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The vaccine delivery supports the Defense Health Agency's medical...
- The Defense Logistics Agency awarded a delivery order valued at $26,253.17 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) under a firm fixed price contract. The order was competitively awarded without set-aside provisions and is scheduled for completion by May 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $62,817.87 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 vaccine in 0.5ml syringes. This competitively awarded, firm fixed-price delivery order is due for completion by September 29, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order valued at $16,337.70 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5 mL), with a firm fixed price and delivery completion by September 15, 2025. This competitively awarded contract, which carries no set-aside designation, represents a single order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $32,675.40 for Prevnar 20 syringes (0.5mL) on September 5, 2025, with completion scheduled for September 8, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical distributor,...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0VM3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,942.30 to AmerisourceBergen Drug Corp for Prevnar 20 syringes (0.5mL) with a firm fixed price arrangement. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of October 22, 2025. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a single procurement action under AmerisourceBergen's larger pharmaceutical supply framework with DLA. This award is executed as a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical federal vendor for military and veteran healthcare systems, supplying vaccines, medications, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's demonstrated capability to fulfill federal medical procurement requirements through open competition positions it as a key supplier supporting Defense Health Agency operations and broader military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 10/21/25 |